Celularity (CELU) FCF Margin (2020 - 2026)
Celularity (CELU) recorded FCF Margin of -124.34% in Q4 2025, down 125.25 percentage points from 0.90% a year earlier and down 45.63 percentage points from the prior quarter.
Powered by 
Analysis
Celularity (CELU) FCF Margin (2020 - 2026) Analysis & Trends
For FY2025, Celularity reported FCF Margin of -49.92%, down 35.35 percentage points from FY2024.
- Annual FCF Margin has a five-year change of +587.61 percentage points (FY2020 to FY2025).
- Across earlier years, FCF Margin came in at -14.57% in FY2024 (+159.92 pp), -174.49% in FY2023 (+621.68 pp), -796.17% in FY2022 (-251.06 pp) and -545.11% in FY2021 (+92.42 pp).
- The Q4 2025 figure is the lowest quarterly FCF Margin since Q3 2023.
- On a year-over-year basis, FCF Margin rose in six of the last eight quarters, with an average year-over-year change of +97.82 percentage points.
- Peak year-over-year performance for FCF Margin in the last five years was a gain of 1020.98 percentage points in Q3 2021, against a drop of 612.18 percentage points in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -78.71% (Q3 2025), -17.42% (Q2 2025) and -26.19% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 30.39% |
| 10 | Celularity | 39.39 Mn | 31.87 Mn | 2.39 Mn | 37.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 37.62% |
| Dec 31, 2025 | -124.34% |
| Sep 30, 2025 | -78.71% |
| Jun 30, 2025 | -17.42% |
| Mar 31, 2025 | -26.19% |
| Dec 31, 2024 | 0.90% |
| Sep 30, 2024 | -1.55% |
| Jun 30, 2024 | -28.73% |
| Mar 31, 2024 | -30.26% |
| Dec 31, 2023 | -40.63% |
| Sep 30, 2023 | -225.83% |
| Jun 30, 2023 | -376.38% |
| Mar 31, 2023 | -386.38% |
| Dec 31, 2022 | -735.38% |
| Sep 30, 2022 | -950.01% |
| Jun 30, 2022 | -999.95% |
| Mar 31, 2022 | -601.63% |
| Dec 31, 2021 | -707.33% |
| Sep 30, 2021 | -337.83% |
| Jun 30, 2021 | -610.20% |
API Access
Celularity FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=CELU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "CELU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=CELU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();